- Home
- Featured Publications
- Center Publications
- Adverse events induced by immune checkpoint inhibitors.
Adverse events induced by immune checkpoint inhibitors.
Citation | “Adverse Events Induced By Immune Checkpoint Inhibitors.”. Current Opinion In Immunology, pp. 29-38. . |
Center | Yale University |
Author | Ana Luisa Perdigoto, Harriet Kluger, Kevan C Herold |
Abstract |
Immune checkpoint inhibitors have revolutionized the treatments of cancers but are also associated with immune related adverse events that can interfere with their use. The types and severity of adverse events vary with checkpoint inhibitors. A single mechanism of pathogenesis has not emerged: postulated mechanisms involve direct effects of the checkpoint inhibitor, emergence of autoantibodies or autoreactive T cells, and destruction by toxic effects of activated T cells. Several host factors such as genotypes, preexisting autoimmune disease, inflammatory responses and others may have predictive value. Ongoing investigations seek to identify ways of modulating the autoimmunity without affecting the anti-tumor response with agents that are specific for the autoimmune mechanisms. |
Year of Publication |
2021
|
Journal |
Current opinion in immunology
|
Volume |
69
|
Number of Pages |
29-38
|
Date Published |
02/2021
|
ISSN Number |
1879-0372
|
DOI |
10.1016/j.coi.2021.02.002
|
Alternate Journal |
Curr Opin Immunol
|
PMID |
33640598
|
Download citation |